{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:10:47Z","timestamp":1790763047614,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD080465"],"award-info":[{"award-number":["R01 HD080465"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI069911"],"award-info":[{"award-number":["U01AI069911"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the absence of clinical trials, data on the safety of medicine exposures in pregnancy are dependent on observational studies conducted after the agent has been licensed for use. This requires an accurate history of antenatal medicine use to determine potential risks. Medication use is commonly determined by self-report, clinician records, and electronic pharmacy data; different data sources may be more informative for different types of medication and resources may differ by setting. We compared three methods to determine antenatal medicine use (self-report, clinician records and electronic pharmacy dispensing records [EDR]) in women attending antenatal care at a primary care facility in Cape Town, South Africa in a setting with high HIV prevalence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Structured, interview-administered questionnaires recorded self-reported medicine use. Data were collected from clinician records and EDR on the same participants. We determined agreement between these data sources using Cohen\u2019s kappa and, lacking a gold standard, used Latent Class Analysis to estimate sensitivity, specificity and positive predictive value (PPV) for each data source.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Between 55% and 89% of 967 women had any medicine use documented depending on the data source (median number of medicines\/participant\u2009=\u20095 [IQR 3\u20136]). Agreement between the datasets was poor regardless of class except for antiretroviral therapy (ART; kappa 0.6\u20130.71). Overall, agreement was better between the EDR and self-report than with either dataset and the clinician records. Sensitivity and PPV were higher for self-report and the EDR and were similar for the two. Self-report was the best source for over-the-counter, traditional and complementary medicines; clinician records for vaccines and supplements; and EDR for chronic medicines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Medicine use in pregnancy was common and no single data source included all the medicines used. ART was the most consistently reported across all three datasets but otherwise agreement between them was poor and dependent on class. Using a single data collection method will under-estimate medicine use in pregnancy and the choice of data source should be guided by the class of the agents being investigated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04765-1","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T07:04:09Z","timestamp":1654239849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment"],"prefix":"10.1186","volume":"22","author":[{"given":"Jani","family":"van der Hoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-6510","authenticated-orcid":false,"given":"Annibale","family":"Cois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-2181","authenticated-orcid":false,"given":"Renee","family":"de Waal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-6606","authenticated-orcid":false,"given":"Gary","family":"Maartens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-5587","authenticated-orcid":false,"given":"Thokozile","family":"Malaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlengiwe","family":"Madlala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Nyemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Phelanyane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-8062","authenticated-orcid":false,"given":"Andrew","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ushma","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-6866","authenticated-orcid":false,"given":"Emma","family":"Kalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"issue":"9","key":"4765_CR1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/pds.2184","volume":"20","author":"JR Daw","year":"2011","unstructured":"Daw JR, Hanley GE, Greyson DL, Morgan SG. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf. 2011;20(9):895\u2013902. https:\/\/doi.org\/10.1002\/pds.2184.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"4765_CR2","first-page":"272","volume":"6","author":"M Mohseni","year":"2018","unstructured":"Mohseni M, Azami-Aghdash S, Gareh Sheyklo S, et al. Prevalence and reasons of self-medication in pregnant women: a systematic review and meta-analysis. Int J Community Based Nurs Midwifery. 2018;6(4):272\u201384.","journal-title":"Int J Community Based Nurs Midwifery"},{"key":"4765_CR3","doi-asserted-by":"publisher","first-page":"205031212093547","DOI":"10.1177\/2050312120935471","volume":"8","author":"Y Ayele","year":"2020","unstructured":"Ayele Y, Mekuria AN, Tola A, Mishore KM, Geleto FB. Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis. SAGE Open Med. 2020;8:2050312120935471. https:\/\/doi.org\/10.1177\/2050312120935471.","journal-title":"SAGE Open Med"},{"issue":"8","key":"4765_CR4","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00228-009-0644-5","volume":"65","author":"Y Potchoo","year":"2009","unstructured":"Potchoo Y, Redah D, Gneni MA, Guissou IP. Prescription drugs among pregnant women in Lome, Togo. West Africa Eur J Clin Pharmacol. 2009;65(8):831\u20138. https:\/\/doi.org\/10.1007\/s00228-009-0644-5.","journal-title":"West Africa Eur J Clin Pharmacol"},{"issue":"1","key":"4765_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12884-018-2081-x","volume":"18","author":"AZ Leke","year":"2018","unstructured":"Leke AZ, Dolk H, Loane M, et al. First trimester medication use in pregnancy in Cameroon: a multi- hospital survey. BMC Pregnancy Childbirth. 2018;18(1):450. https:\/\/doi.org\/10.1186\/s12884-018-2081-x.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"4765_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.7196\/SAMJ.2019.v109i5.14008","volume":"109","author":"U Mehta","year":"2019","unstructured":"Mehta U, Kalk E, Fairlie L, Boulle A, Rees H. Why South Africa urgently needs to support the development of pregnancy exposure registries. S Afr Med J. 2019;109(5):294\u20135. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i5.14008.","journal-title":"S Afr Med J"},{"key":"4765_CR7","doi-asserted-by":"publisher","unstructured":"Stock SJE, Norman JE. Medicines in Pregnancy. F1000Research 2019;8(F1000 Faculty Rev)(911) doi: https:\/\/doi.org\/10.12688\/f1000research.17535.1.","DOI":"10.12688\/f1000research.17535.1"},{"key":"4765_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12913-014-0525-1","volume":"14","author":"EN Allen","year":"2014","unstructured":"Allen EN, Gomes M, Yevoo L, et al. Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study. BMC Health Serv Res. 2014;14:525. https:\/\/doi.org\/10.1186\/s12913-014-0525-1.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"4765_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.reprotox.2012.01.006","volume":"33","author":"LE Grzeskowiak","year":"2012","unstructured":"Grzeskowiak LE, Gilbert AL, Morrison JL. Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs. Reprod Toxicol. 2012;33(3):280\u20139. https:\/\/doi.org\/10.1016\/j.reprotox.2012.01.006.","journal-title":"Reprod Toxicol"},{"issue":"3","key":"4765_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/QAI.0000000000002236","volume":"83","author":"TK Phillips","year":"2020","unstructured":"Phillips TK, Mogoba P, Brittain K, et al. Long-term outcomes of HIV-infected women receiving antiretroviral therapy after transferring out of an integrated maternal and child health service in South Africa. J Acquir Immune Defic Syndr. 2020;83(3):202\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002236.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"4765_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/BF00315343","volume":"45","author":"LT de Jong-van den Berg","year":"1993","unstructured":"de Jong-van den Berg LT, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MN, Wesseling H. Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol. 1993;45(1):9\u201314.","journal-title":"Eur J Clin Pharmacol"},{"key":"4765_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95: 103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"4765_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010|","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010|.","journal-title":"J Biomed Inform"},{"key":"4765_CR14","unstructured":"Kalk E, Mehta U, Slogrove A, et al. Pregnancy Exposire Registry\/Birth Defects Surveillance Programme in the Western Cape, South Africa: a Model for Low- and Middle-Income Countries. Drug Safety 2018;41(11):1212\u201313."},{"issue":"2","key":"4765_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.23889\/ijpds.v4i2.1143","volume":"4","author":"A Boulle","year":"2019","unstructured":"Boulle A, Heekes A, Tiffin N, et al. Data centre profile: the provincial health data centre of the Western Cape Province, South Africa. Int J Popul Data Sci. 2019;4(2):1143. https:\/\/doi.org\/10.23889\/ijpds.v4i2.1143.","journal-title":"Int J Popul Data Sci"},{"key":"4765_CR16","unstructured":"World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification\/. Accessed 01 Oct\u00a02021."},{"key":"4765_CR17","unstructured":"World Health Organization. The Herbal Anatomical Therapeutic Chemical Classification System. Secondary The Herbal Anatomical Therapeutic Chemical Classification System 2020. https:\/\/www.who-umc.org\/whodrug\/whodrug-portfolio\/whodrug-global\/herbal-atc\/. Accessed 01 Oct\u00a02021."},{"key":"4765_CR18","unstructured":"South African Department of Health. Guideline for the Prevention of Mother to Child Transmission of Communicable Diseases. In: Health, ed. Pretoria. 2019.\u00a0https:\/\/www.nicd.ac.za\/wp-content\/uploads\/2019\/11\/Guidelines-for-the-Prevention-of-Transmission-of-Communicable-Diseases-from-mother-to-child_28-October.pdf. Accessed 01 Oct 2021."},{"key":"4765_CR19","unstructured":"South African Department of Health. Standard Treatment Guidelines and Essential Medicines List for South Africa 2018 Edition. In: Health, ed. Pretoria, 2018.\u00a0https:\/\/www.knowledgehub.org.za\/system\/files\/elibdownloads\/2021-02\/Primary%20Healthcare%20STGs%20and%20EML%207th%20edition%20-%202020-v2.0.pdf. Accessed 01 Oct 2021."},{"key":"4765_CR20","unstructured":"Oliveros JC. Venny. An interactive tool for comparing lists with Venn's diagrams. Secondary Venny. AninteractivetoolforcomparinglistswithVenn'sdiagrams2007\u20132015.https:\/\/bioinfogp.cnb.csic.es\/tools\/venny\/index.html. Accessed 01 Oct 2021."},{"issue":"1","key":"4765_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"4","key":"4765_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/aje\/kwt286","volume":"179","author":"M van Smeden","year":"2014","unstructured":"van Smeden M, Naaktgeboren CA, Reitsma JB, Moons KG, de Groot JA. Latent class models in diagnostic studies when there is no reference standard\u2013a systematic review. Am J Epidemiol. 2014;179(4):423\u201331. https:\/\/doi.org\/10.1093\/aje\/kwt286.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"4765_CR23","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1017\/S0950268818001723","volume":"146","author":"J Asselineau","year":"2018","unstructured":"Asselineau J, Paye A, Bessede E, Perez P, Proust-Lima C. Different latent class models were used and evaluated for assessing the accuracy of campylobacter diagnostic tests: overcoming imperfect reference standards? Epidemiol Infect. 2018;146(12):1556\u201364. https:\/\/doi.org\/10.1017\/S0950268818001723.","journal-title":"Epidemiol Infect"},{"issue":"13","key":"4765_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v081.i13","volume":"81","author":"KJ Beeath","year":"2017","unstructured":"Beeath KJ. Random LCA: An R package for latent class with random effects analysis. J Stat Softw. 2017;81(13):1\u201325.","journal-title":"J Stat Softw"},{"key":"4765_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01093-9","author":"GN Okoli","year":"2021","unstructured":"Okoli GN, Myles P, Murray-Thomas T, Shepherd H, Wong ICK, Edwards D. Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent. Drug Saf. 2021. https:\/\/doi.org\/10.1007\/s40264-021-01093-9.","journal-title":"Drug Saf"},{"issue":"5","key":"4765_CR26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7196\/SAMJ2018.v108i5.12879","volume":"108","author":"U Mehta","year":"2018","unstructured":"Mehta U, Heekes A, Kalk E, Boulle A. Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy. S Afr Med J. 2018;108(5):439\u201343. https:\/\/doi.org\/10.7196\/SAMJ2018.v108i5.12879.","journal-title":"S Afr Med J"},{"key":"4765_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/CLEP.S16305","volume":"3","author":"O Stephansson","year":"2011","unstructured":"Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011;3:43\u201350. https:\/\/doi.org\/10.2147\/CLEP.S16305.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"4765_CR28","first-page":"84","volume":"6","author":"EP Gharoro","year":"2000","unstructured":"Gharoro EP, Igbafe AA. Pattern of drug use amongst antenatal patients in Benin City. Nigeria Med Sci Monit. 2000;6(1):84\u20137.","journal-title":"Nigeria Med Sci Monit"},{"key":"4765_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2393-14-322","volume":"14","author":"D Mosha","year":"2014","unstructured":"Mosha D, Mazuguni F, Mrema S, Abdulla S, Genton B. Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform. BMC Pregnancy Childbirth. 2014;14:322. https:\/\/doi.org\/10.1186\/1471-2393-14-322.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"4765_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12884-020-03327-7","volume":"20","author":"NM Alema","year":"2020","unstructured":"Alema NM, Semagn G, Melesse S, et al. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study. BMC Pregnancy Childbirth. 2020;20(1):624. https:\/\/doi.org\/10.1186\/s12884-020-03327-7.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"4765_CR31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s11096-011-9556-4","volume":"33","author":"KB Yusuff","year":"2011","unstructured":"Yusuff KB, Omarusehe LD. Determinants of self medication practices among pregnant women in Ibadan. Nigeria Int J Clin Pharm. 2011;33(5):868\u201375. https:\/\/doi.org\/10.1007\/s11096-011-9556-4.","journal-title":"Nigeria Int J Clin Pharm"},{"issue":"9","key":"4765_CR32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jclinepi.2007.10.021","volume":"61","author":"MW Nielsen","year":"2008","unstructured":"Nielsen MW, Sondergaard B, Kjoller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. J Clin Epidemiol. 2008;61(9):919\u201324. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.10.021.","journal-title":"J Clin Epidemiol"},{"key":"4765_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12884-015-0745-3","volume":"15","author":"FE Pisa","year":"2015","unstructured":"Pisa FE, Casetta A, Clagnan E, Michelesio E, Vecchi Brumatti L, Barbone F. Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort. BMC Pregnancy Childbirth. 2015;15:310. https:\/\/doi.org\/10.1186\/s12884-015-0745-3.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"4765_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ppe.12415","volume":"32","author":"K Palmsten","year":"2018","unstructured":"Palmsten K, Hulugalle A, Bandoli G, et al. Agreement between maternal report and medical records during pregnancy: medications for rheumatoid arthritis and asthma. Paediatr Perinat Epidemiol. 2018;32(1):68\u201377. https:\/\/doi.org\/10.1111\/ppe.12415.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"3","key":"4765_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pds.2085","volume":"20","author":"MG Espnes","year":"2011","unstructured":"Espnes MG, Bjorge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf. 2011;20(3):243\u20138. https:\/\/doi.org\/10.1002\/pds.2085.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4765_CR36","doi-asserted-by":"publisher","unstructured":"Lupattelli A, Picinardi M, Cantarutti A, Nordeng H. Use and Intentional Avoidance of Prescribed Medications in Pregnancy: A Cross-Sectional, Web-Based Study among 926 Women in Italy. Int J Environ Res Public Health 2020;17(11) doi: https:\/\/doi.org\/10.3390\/ijerph17113830.","DOI":"10.3390\/ijerph17113830"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04765-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T07:05:32Z","timestamp":1654239932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04765-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4765"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04765-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The parent and sub-studies were approved by the University of Cape Town Human Research Ethics Committee (REF 541\/2015, 749\/2015 and 197\/2020) and the Western Cape Government Department of Health Provincial Health Research Committee (REF WC_2016RP6_286). All women provided written informed consent including for access to their clinical records and linked electronic health information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"EK and AB received funding from Viiv Healthcare unrelated to this project.The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}